MICROSPORIDIA INFECTION

MICROSPORIDIA INFECTION was reported 351 times

MICROSPORIDIA INFECTION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD52-directed Cytolytic Antibody [EPC] 64 0.0033
1 Antiprotozoal [EPC] 31 0.0029
2 Anthelmintic [EPC] 8 0.0028
3 Vitamin D3 Analog [EPC] 37 0.0018
4 Rifamycin Antimycobacterial [EPC] 4 0.0011
5 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 18 0.0008
6 Antimetabolite Immunosuppressant [EPC] 17 0.0008
7 Azole Antifungal [EPC] 82 0.0005
8 Sulfonamide Antibacterial [EPC] 2 0.0005
9 Lipid-based Polyene Antifungal [EPC] 5 0.0004
10 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 31 0.0003
11 Alkylating Drug [EPC] 77 0.0003
12 alpha-Adrenergic Blocker [EPC] 31 0.0002
13 Corticosteroid [EPC] 254 0.0002
14 CD20-directed Cytolytic Antibody [EPC] 61 0.0002
15 Xanthine Oxidase Inhibitor [EPC] 33 0.0002
16 Calcineurin Inhibitor Immunosuppressant [EPC] 24 0.0002
17 CD38-directed Cytolytic Antibody [EPC] 1 0.0002
18 Kinase Inhibitor [EPC] 94 0.0002
19 Antirheumatic Agent [EPC] 17 0.0002
20 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 7 0.0001
21 Polyene Antifungal [EPC] 5 0.0001
22 Cannabinoid [EPC] 1 0.0001
23 Antimycobacterial [EPC] 3 0.0001
24 Echinocandin Antifungal [EPC] 1 0.0001
25 Purine Antimetabolite [EPC] 11 0.0001
26 Erythropoiesis-stimulating Agent [EPC] 6 0.0001
27 Quinolone Antimicrobial [EPC] 1 0.0001
28 beta-Adrenergic Blocker [EPC] 31 0.0001
29 Provitamin D2 Compound [EPC] 3 0.0001
30 CD19-directed Chimeric Antigen Receptor [EPC] 1 0.0001
31 Proteasome Inhibitor [EPC] 11 0.0001
32 Human Immunoglobulin G [EPC] 2 0.0001
33 Topoisomerase Inhibitor [EPC] 7 0.0001
34 Aminoglycoside Antibacterial [EPC] 4 0.0001
35 Insulin [EPC] 4 0.0001
36 Insulin Analog [EPC] 38 0.0001
37 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0001
38 Loop Diuretic [EPC] 38 0.0001
39 Folate Analog Metabolic Inhibitor [EPC] 36 0.0001
40 Macrolide Antimicrobial [EPC] 4 0.0001
41 Nucleoside Analog Antiviral [EPC] 6 0.0001
42 Dihydropyridine Calcium Channel Blocker [EPC] 23 0.0001
43 Protease Inhibitor [EPC] 3 0.0001
44 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 7 0.0001
45 B Lymphocyte Stimulator-specific Inhibitor [EPC] 2 0.0001
46 Nucleoside Metabolic Inhibitor [EPC] 10 0.0000
47 Cytochrome P450 3A Inhibitor [EPC] 2 0.0000
48 Oxazolidinone Antibacterial [EPC] 1 0.0000
49 RANK Ligand Inhibitor [EPC] 6 0.0000
50 Penem Antibacterial [EPC] 1 0.0000
51 Platinum-based Drug [EPC] 7 0.0000
52 Acetylcholine Release Inhibitor [EPC] 2 0.0000
53 Janus Kinase Inhibitor [EPC] 3 0.0000
54 Osmotic Laxative [EPC] 5 0.0000
55 BCL-2 Inhibitor [EPC] 1 0.0000
56 Fluoroquinolone Antibacterial [EPC] 2 0.0000
57 Nitroimidazole Antimicrobial [EPC] 1 0.0000
58 Tetracycline-class Drug [EPC] 1 0.0000
59 Proton Pump Inhibitor [EPC] 8 0.0000
60 Tumor Necrosis Factor Blocker [EPC] 13 0.0000
61 Integrin Receptor Antagonist [EPC] 1 0.0000
62 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
63 Sulfonylurea [EPC] 1 0.0000
64 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
65 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
66 Microtubule Inhibitor [EPC] 1 0.0000
67 Factor Xa Inhibitor [EPC] 1 0.0000
68 Thalidomide Analog [EPC] 1 0.0000
69 Platelet Aggregation Inhibitor [EPC] 1 0.0000
70 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000